Sight Sciences, Inc.
SGHT
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology forā¦ read more
Healthcare
Medical Devices
5 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$5.53
Price+5.13%
$0.27
1Y
Price
Market Cap
$300.887m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-58.9%
EBITDA Margin-65.9%
Net Profit Margin-36.0%
Free Cash Flow Margin-58.9%
EBITDA Margin-65.9%
Net Profit Margin-36.0%
Free Cash Flow MarginRevenue
$79.553m
+2.8%
1y CAGR-0.6%
3y CAGR+3.0%
5y CAGREarnings
-$37.252m
+3.1%
1y CAGR+11.9%
3y CAGR+17.8%
5y CAGREPS
-$0.71
+4.1%
1y CAGR+14.0%
3y CAGR+19.6%
5y CAGRBook Value
$53.903m
$109.702m
Assets$55.799m
Liabilities$41.761m
DebtDebt to Assets
38.1%
-1.3x
Debt to EBITDAFree Cash Flow
-$25.402m
+15.1%
1y CAGR+12.0%
3y CAGR+18.4%
5y CAGRNo items found.
Press Releases
Statements and updates from the company